Previous Close | 5.75 |
Open | 5.65 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's Range | 5.65 - 5.65 |
52 Week Range | 5.15 - 10.00 |
Volume | |
Avg. Volume | 81 |
Market Cap | 2.44B |
Beta (5Y Monthly) | 1.00 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -3.68 |
Earnings Date | Nov 06, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | Apr 19, 2022 |
1y Target Est | 23.31 |
The average of price targets set by Wall Street analysts indicates a potential upside of 46.2% in Braskem (BAK). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
PHILADELPHIA, August 12, 2024--Braskem (B3: BRKM3, BRKM5, and BRKM6; NYSE: BAK; LATIBEX: XBRK) the largest polyolefins producer in the Americas, as well as a global market leader and pioneer producer of biopolymers on an industrial scale, and WEAV3D Inc., an advanced manufacturing and materials startup, today announced Braskem's and WEAV3D Inc.'s thermoplastic composite lattice technology, in partnership with the Clemson Composites Center at Clemson University, were named first place winners of
BRASKEM S.A. (B3: BRKM3, BRKM5 and BRKM6; NYSE: BAK; LATIBEX: XBRK) the largest resin producer in the Americas and the world's leading biopolymers producer, presents its 2Q24 Earnings Release.